References
Lip GY, Andreotti F, Fauchier L et al (2011) Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 13:723–746
Ahmed I, Gertner E, Nelson WB et al (2010) Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm 7:745–749
Alexander B (1959) Clotting factor VII (proconvertin): synonymy, properties, clinical and clinicolaboratory aspects. N Engl J Med 260:1218–1222
Jayandharan GR, Viswabandya A, Nair SC et al (2007) Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients. Haematologica 92(7):1002–1003
Mariani G, Dolce A, Napolitano M et al (2012) Invasive procedures and minor surgery in factor VII deficiency. Haemophilia 18:e63–e65
Raskob GE, Durica S, Morrissey JH, Owen WL, Comp PC (1995) Effect of treatment with low-dose warfarin-aspirin on activated Factor VI1. Blood 85(11):3034–3039
Sakata T, Kario K, Matsuo T, Katayama Y, Matsuyama T, Kato H, Miyata T (1995) Suppression of plasma-activated factor VII levels by warfarin therapy. Arterioscler Thromb Vasc Biol 15(2):241–246
Palareti G, Legnani C (1996) Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 30(4):300–313
Robinson M, Healey JS, Eikelboom J et al (2009) Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 32:378–382
Haghpanah S, Vafafar A, Golzadeh MH et al (2011) Use of Glubran 2 and Glubran tissue skin adhesive in patients with hereditary bleeding disorders undergoing circumcision and dental extraction. Ann Hematol 90:463–468
Gandini R, Angelopoulos G, Konda D et al (2008) Transcatheter embolization of a large symptomatic pelvic arteriovenous malformation with Glubran 2 acrylic glue. Cardiovasc Intervent Radiol 31(5):1030–1033
Conflict of interest
Francesco Sbrana, Michele Coceani, Luca Panchetti, Emilio Maria Pasanisi, Daniele Rovai, and Andrea Del Corso have no conflict of interest to report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sbrana, F., Coceani, M., Panchetti, L. et al. Factor VII Deficiency, Masked by Warfarin Therapy, as a Cause of Bleeding After Cardiovascular Intervention. Cardiovasc Intervent Radiol 36, 1180–1183 (2013). https://doi.org/10.1007/s00270-012-0521-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-012-0521-y